Carol B. Bolden

721 total citations
7 papers, 591 citations indexed

About

Carol B. Bolden is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carol B. Bolden has authored 7 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carol B. Bolden's work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (7 papers) and Respiratory and Cough-Related Research (2 papers). Carol B. Bolden is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (7 papers) and Respiratory and Cough-Related Research (2 papers). Carol B. Bolden collaborates with scholars based in United States and India. Carol B. Bolden's co-authors include Shawn R. Lockhart, Naureen Iqbal, Angela A. Cleveland, Monica M. Farley, Benjamin J. Park, Lee H. Harrison, Tom Chiller, R J Kuykendall, Cau D. Pham and Wendy Baughman and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Diagnostic Microbiology and Infectious Disease.

In The Last Decade

Carol B. Bolden

7 papers receiving 583 citations

Peers

Countries citing papers authored by Carol B. Bolden

Since Specialization

Citations

This map shows the geographic impact of Carol B. Bolden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol B. Bolden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol B. Bolden more than expected).

Fields of papers citing papers by Carol B. Bolden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol B. Bolden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol B. Bolden. The network helps show where Carol B. Bolden may publish in the future.

Co-authorship network of co-authors of Carol B. Bolden

This figure shows the co-authorship network connecting the top 25 collaborators of Carol B. Bolden. A scholar is included among the top collaborators of Carol B. Bolden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol B. Bolden. Carol B. Bolden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii 2016 ·Antimicrobial Agents and Chemotherapy ·Shawn R. Lockhart, Annette W. Fothergill, Naureen Iqbal, Carol B. Bolden, Nina T. Grossman, Edward P. Garvey, Stephen Brand, William J. Hoekstra, Robert J. Schotzinger, Elizabeth A. Ottinger, Thomas F. Patterson, Nathan P. Wiederhold	54
2	Candida lusitaniae MICs to the echinocandins are elevated but FKS -mediated resistance is rare 2015 ·Diagnostic Microbiology and Infectious Disease ·Shawn R. Lockhart, Cau D. Pham, R J Kuykendall, Carol B. Bolden, Angela A. Cleveland	8
3	Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance 2014 ·Antimicrobial Agents and Chemotherapy ·Cau D. Pham, Naureen Iqbal, Carol B. Bolden, R J Kuykendall, Lee H. Harrison, Monica M. Farley, William Schaffner, Zintars G. Beldavs, Tom Chiller, Benjamin J. Park, Angela A. Cleveland, Shawn R. Lockhart	186
4	Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata 2013 ·Journal of Clinical Microbiology ·Cau D. Pham, Carol B. Bolden, R J Kuykendall, Shawn R. Lockhart	39
5	Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility 2012 ·Diagnostic Microbiology and Infectious Disease ·Shawn R. Lockhart, Naureen Iqbal, Carol B. Bolden, Emilio DeBess, Nicola Marsden-Haug, (unknown), Rameshwari Thakur, Julie R. Harris	51
6	Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011 2012 ·Journal of Clinical Microbiology ·Shawn R. Lockhart, Naureen Iqbal, Angela A. Cleveland, Monica M. Farley, Lee H. Harrison, Carol B. Bolden, Wendy Baughman, Betsy Stein, Rosemary Hollick, Benjamin J. Park, Tom Chiller	239
7	Validation of 24-Hour Flucytosine MIC Determination by Comparison with 48-Hour Determination by the Clinical and Laboratory Standards Institute M27-A3 Broth Microdilution Reference Method 2011 ·Journal of Clinical Microbiology ·Shawn R. Lockhart, Carol B. Bolden, Naureen Iqbal, R J Kuykendall	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact